Petra Leiding is Director of Market Intelligence & Strategic Projects at HELM AG, where she has worked for over seven years. She specializes in uncovering market insights to drive new business opportunities at HELM Pharma. Petra promotes 2 and 3D printing opportunities including project lead of technical development, market access and financials. Previously, Petra held team leader roles in business insights and analytics at Teva Pharmaceuticals and AstraZeneca, bringing overall more than 25 years of professional experience in market research, pricing, and strategies mostly within the pharmaceutical industry.

The Pop in Your Job
I love transforming complex data into intelligent, automated solutions that truly make an impact. Seeing how AI and automation streamline workflows, empower teams and at the same time gives freedom for strategic projects as well as in depths analyses motivates me every day!

HELM Pharma is a subsidiary of HELM AG a Hamburg-based family company established in 1900. With over 1,621 employees, HELM AG is one of the world’s largest independent chemicals marketing companies. The Company secures access to the world’s key markets through its specific regional knowledge and over 100 branches, sales offices and participations in over 30 countries. HELM Pharma as a digital company develops plain as well as highly specialized and added-value generics to be marketed by partners mainly in Europe, USA and MENA.